BCRX - CIK 0000882796
BIOCRYST PHARMACEUTICALS INC (BCRX) reported revenue of $25.19M for fiscal year 2017, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2017 | $25.19M | -4.4% |
| FY 2016 | $26.35M | -45.4% |
| FY 2015 | $48.26M | +254.6% |
| FY 2014 | $13.61M | -21.5% |
| FY 2013 | $17.33M | -34.1% |
| FY 2012 | $26.29M | +33.9% |
| FY 2011 | $19.64M | -68.5% |
| FY 2010 | $62.38M | -16.4% |
| FY 2009 |
BIOCRYST PHARMACEUTICALS INC (BCRX) reported revenue of $25.19M for fiscal year 2017, as filed in its audited annual report with the SEC.
Between fiscal 2009 and fiscal 2017, BIOCRYST PHARMACEUTICALS INC's revenue declined from $74.59M to $25.19M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $74.59M |
| - |